The Schisandra Market size is expected to grow at an annual average of 6% during 2022-2028. Schisandra chinensis is a traditional Chinese medicine that has been widely used in China to treat acute myocardial infarction. However, it was difficult to systematically identify the major pharmacological effects of omijae due to the multi-component complex mechanism. To […]
